191 related articles for article (PubMed ID: 19221430)
1. nELAV proteins alteration in Alzheimer's disease brain: a novel putative target for amyloid-beta reverberating on AbetaPP processing.
Amadio M; Pascale A; Wang J; Ho L; Quattrone A; Gandy S; Haroutunian V; Racchi M; Pasinetti GM
J Alzheimers Dis; 2009; 16(2):409-19. PubMed ID: 19221430
[TBL] [Abstract][Full Text] [Related]
2. PKC Activation Counteracts ADAM10 Deficit in HuD-Silenced Neuroblastoma Cells.
Marchesi N; Amadio M; Colombrita C; Govoni S; Ratti A; Pascale A
J Alzheimers Dis; 2016 Sep; 54(2):535-47. PubMed ID: 27472877
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of non-amyloidogenic processing of amyloid-β protein precursor by cryptotanshinone involves activation and translocation of ADAM10 and PKC-α.
Durairajan SS; Liu LF; Lu JH; Koo I; Maruyama K; Chung SK; Huang JD; Li M
J Alzheimers Dis; 2011; 25(2):245-62. PubMed ID: 21403388
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E-mediated Modulation of ADAM10 in Alzheimer's Disease.
Shackleton B; Crawford F; Bachmeier C
Curr Alzheimer Res; 2017; 14(6):578-585. PubMed ID: 28164773
[TBL] [Abstract][Full Text] [Related]
5. Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model.
Durairajan SS; Liu LF; Lu JH; Chen LL; Yuan Q; Chung SK; Huang L; Li XS; Huang JD; Li M
Neurobiol Aging; 2012 Dec; 33(12):2903-19. PubMed ID: 22459600
[TBL] [Abstract][Full Text] [Related]
6. Activation of peroxisome proliferator-activated receptor α stimulates ADAM10-mediated proteolysis of APP.
Corbett GT; Gonzalez FJ; Pahan K
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8445-50. PubMed ID: 26080426
[TBL] [Abstract][Full Text] [Related]
7. Targeting ADAM10 to lipid rafts in neuroblastoma SH-SY5Y cells impairs amyloidogenic processing of the amyloid precursor protein.
Harris B; Pereira I; Parkin E
Brain Res; 2009 Nov; 1296():203-15. PubMed ID: 19679113
[TBL] [Abstract][Full Text] [Related]
8. Melatonin regulates the transcription of βAPP-cleaving secretases mediated through melatonin receptors in human neuroblastoma SH-SY5Y cells.
Panmanee J; Nopparat C; Chavanich N; Shukla M; Mukda S; Song W; Vincent B; Govitrapong P
J Pineal Res; 2015 Oct; 59(3):308-20. PubMed ID: 26123100
[TBL] [Abstract][Full Text] [Related]
9. A novel blood-brain barrier co-culture system for drug targeting of Alzheimer's disease: establishment by using acitretin as a model drug.
Freese C; Reinhardt S; Hefner G; Unger RE; Kirkpatrick CJ; Endres K
PLoS One; 2014; 9(3):e91003. PubMed ID: 24608847
[TBL] [Abstract][Full Text] [Related]
10. ADAM10 expression and promoter haplotype in Alzheimer's disease.
Bekris LM; Lutz F; Li G; Galasko DR; Farlow MR; Quinn JF; Kaye JA; Leverenz JB; Tsuang DW; Montine TJ; Peskind ER; Yu CE
Neurobiol Aging; 2012 Sep; 33(9):2229.e1-2229.e9. PubMed ID: 22572541
[TBL] [Abstract][Full Text] [Related]
11. Palmitate Increases β-site AβPP-Cleavage Enzyme 1 Activity and Amyloid-β Genesis by Evoking Endoplasmic Reticulum Stress and Subsequent C/EBP Homologous Protein Activation.
Marwarha G; Rostad S; Lilek J; Kleinjan M; Schommer J; Ghribi O
J Alzheimers Dis; 2017; 57(3):907-925. PubMed ID: 28304295
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-144 is regulated by activator protein-1 (AP-1) and decreases expression of Alzheimer disease-related a disintegrin and metalloprotease 10 (ADAM10).
Cheng C; Li W; Zhang Z; Yoshimura S; Hao Q; Zhang C; Wang Z
J Biol Chem; 2013 May; 288(19):13748-61. PubMed ID: 23546882
[TBL] [Abstract][Full Text] [Related]
13. Auraptene increases the production of amyloid-β via c-Jun N-terminal kinase-dependent activation of γ-secretase.
Jung CG; Uhm KO; Horike H; Kim MJ; Misumi S; Ishida A; Ueda Y; Choi EK; Kim YS; Michikawa M; Hida H
J Alzheimers Dis; 2015; 43(4):1215-28. PubMed ID: 25147119
[TBL] [Abstract][Full Text] [Related]
14. Endocytosis of synaptic ADAM10 in neuronal plasticity and Alzheimer's disease.
Marcello E; Saraceno C; Musardo S; Vara H; de la Fuente AG; Pelucchi S; Di Marino D; Borroni B; Tramontano A; Pérez-Otaño I; Padovani A; Giustetto M; Gardoni F; Di Luca M
J Clin Invest; 2013 Jun; 123(6):2523-38. PubMed ID: 23676497
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol Intervenes Cholesterol- and Isoprenoid-Mediated Amyloidogenic Processing of AβPP in Familial Alzheimer's Disease.
Sathya M; Moorthi P; Premkumar P; Kandasamy M; Jayachandran KS; Anusuyadevi M
J Alzheimers Dis; 2017; 60(s1):S3-S23. PubMed ID: 28059793
[TBL] [Abstract][Full Text] [Related]
16. Genetic Deletion of Tumor Necrosis Factor-α Attenuates Amyloid-β Production and Decreases Amyloid Plaque Formation and Glial Response in the 5XFAD Model of Alzheimer's Disease.
Paouri E; Tzara O; Zenelak S; Georgopoulos S
J Alzheimers Dis; 2017; 60(1):165-181. PubMed ID: 28826177
[TBL] [Abstract][Full Text] [Related]
17. Double-Edged Roles of Nitric Oxide Signaling on APP Processing and Amyloid-β Production In Vitro: Preliminary Evidence from Sodium Nitroprusside.
Cai ZX; Guo HS; Wang C; Wei M; Cheng C; Yang ZF; Chen YW; Le WD; Li S
Neurotox Res; 2016 Jan; 29(1):21-34. PubMed ID: 26429731
[TBL] [Abstract][Full Text] [Related]
18. PCP4 Promotes Alzheimer's Disease Pathogenesis by Affecting Amyloid-β Protein Precursor Processing.
Hu D; Dong X; Wang Q; Liu M; Luo S; Meng Z; Feng Z; Zhou W; Song W
J Alzheimers Dis; 2023; 94(2):737-750. PubMed ID: 37302034
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.
Shackleton B; Crawford F; Bachmeier C
Fluids Barriers CNS; 2016 Aug; 13(1):14. PubMed ID: 27503326
[TBL] [Abstract][Full Text] [Related]
20. Huperzine A regulates amyloid precursor protein processing via protein kinase C and mitogen-activated protein kinase pathways in neuroblastoma SK-N-SH cells over-expressing wild type human amyloid precursor protein 695.
Peng Y; Lee DY; Jiang L; Ma Z; Schachter SC; Lemere CA
Neuroscience; 2007 Dec; 150(2):386-95. PubMed ID: 17945434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
